China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.SZSE: 000999

China Resources Sanjiu Medical & Pharmaceutical Co: Revenue surged but profit declined as acquisition and investment costs rose sharply

· Issued by China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

Q3 2025 revenue grew 27.37% year-over-year, but net profit fell 4.26% and year-to-date profit dropped 20.51%. The Tian Shi Li acquisition drove major asset and liability increases, while higher R&D and financing costs pressured margins.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. on 6ix

Story so far

Earlier from China Resources Sanjiu Medical & Pharmaceutical

Later from China Resources Sanjiu Medical & Pharmaceutical

All China Resources Sanjiu Medical & Pharmaceutical news releases